How to recognize systemic sclerosis;Comment reconnaître une sclérodermie

Revue du Praticien

Volumn 52, Issue 17, 2002, Pages 1884-1890

  Francés, Camille ^a   Ayoub, Nakhle ^a   Barete, Stéphane ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CENTROMERE ANTIBODY; DNA TOPOISOMERASE INHIBITOR;

ARTERY DISEASE; AUTOIMMUNE DISEASE; CALCIFICATION; CONNECTIVE TISSUE DISEASE; DIFFERENTIAL DIAGNOSIS; DISABILITY; GASTROINTESTINAL DISEASE; HISTOPATHOLOGY; HUMAN; LUNG FIBROSIS; MICROANGIOPATHY; MORPHEA; MYOCARDIAL DISEASE; NAIL DISEASE; PROGNOSIS; PULMONARY HYPERTENSION; RAYNAUD PHENOMENON; REVIEW; SCLERODERMA; SYNDROME CREST; SYSTEMIC SCLEROSIS; TELANGIECTASIA; VASCULAR DISEASE;

DIAGNOSIS, DIFFERENTIAL; HUMANS; PROGNOSIS; RAYNAUD DISEASE; SCLERODERMA, SYSTEMIC; SCLEROSIS; SKIN;

EID: 0036847157     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (13)

1. Fautrel B, Aeschlimann A, Bourgeois-Droin C, Bourgeois P. Sclérodermies. In: Kahn MF, Peltier AP, Meyer O, Piette JC (eds). Maladies et Syndromes Systémiques. Paris: Flammarion Médecine-Sciences, 2000: 469-532.
2. Fregeau DR, Leung PS, Coppel RL et al. Autoantibodies to mitochondria in systemic sclerosis: Frequency and characterization using recombinant cloned autoantigen. Arthritis Rheum 1988; 31: 386-92.
3. LeRoy EC, Black C, Fleischmajer R et al. Scleroderma (systemic sclerosis) Classification, subsets and pathogenesis. J Rheumatol 1988; 15: 202-5.
4. Poormoghim H, Lucas M, Fertig N, Medgser TA Jr. Systemic sclerosis sine scleroderma. Arthritis Rheum 2000; 43: 444-51.
5. Masi AT. Classification of systemic sclerosis (scleroderma): Relationship of cutaneous subgroups in early disease to outcome and serologic reactivity. J Rheumatol 1988; 15: 894-8.
6. LeRoy EC, Medgser TA Jr. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001; 28: 1573-6.
7. Falanga V, Medsger TA, Reichlin M. Antinuclear and anti-single-stranded DNA antibodies in morphea and generalized morphea. Arch Dermatol 1987; 123: 350.
8. Fontan I, Taïeb A, Guillet G et al. Les perturbations immunologiques dans les sclérodermies en bande de l'enfant. À propos de 11 cas. Ann Dermatol Venereol 1988; 115: 135-41.
9. Sharp GC, Irvin WS, Tan EM et al. Mixed connective tissue: an apparently distinct rheumatic disease syndrome associated with a specific antibody to extractable nuclear antigen (ENA) Am J Med 1972; 52: 148-9.
10. Hayem G, Kahn MF. Syndrome de sharp et connectivites mixtes. In: Kahn MF, Peltier AP, Meyer O, Piette JC. Maladies et Syndromes Systémiques. Paris: Flammarion Médecine-Sciences, 2000: 575-96.
11. Palazzo E, Kahn MF, Grossin M. Fasciite avec éosinophilie (syndrome de Shulman) In: Kahn MF, Peltier AP, Meyer O, Piette JC (eds). Maladies et Syndromes Systémiques. Paris: Flammarion Médecine-Sciences, 2000: 523-32.
12. Mori Y, Kahari VM, Varga J. Scleroderma-like cutaneous syndromes. Curr Rheumatol Rep 2002; 4: 113-22.
13. Rongioletti F, Rebora A. Updated classification of papular mucinosis, lichen myxedematous and scleromyxedema. J Am Acad Dermatol 2001; 44: 273-81.